RNS Number : 0742D
Collagen Solutions PLC
23 October 2020
Collagen Solutions plc
("Collagen Solutions" or the "Company")
Result of AGM
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
Full details of the voting results will be available on the Company website at https://www.collagensolutions.com/.
|
Collagen Solutions Plc |
|
||||
|
Jamal Rushdy, CEO |
Via Walbrook |
||||
|
Hilary Spence, CFO |
|
||||
|
|
|
||||
|
|
|
||||
|
Cenkos Securities Plc (Nominated Adviser and Broker) |
|
||||
|
Giles Balleny |
Tel: 0207 397 8900 |
||||
|
Stephen Keys |
|
||||
|
|
|
||||
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or collagen@walbrookpr.com |
||||
|
Anna Dunphy |
Mob: 07876 741 001 |
||||
|
|
|
||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
